Kennedy Jr. passed the Senate Finance ... Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Kennedy Jr. passed the Senate Finance ... Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
NVAX), a global company advancing protein-based vaccines with its novel Matrix-Mâ„¢ adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units to ...
If you are building a properly diversified stock portfolio ... Let's look at five biotech and drug companies, AZN, NVAX, AXSM, TBPH and PRTA, slated to release their third-quarter 2024 results ...
The Company was notified that the FDA requires additi PBPB, BBCP, BAK, NVAX and ETON have been added ... estimate revisions might not help the stock continue moving higher in the near term.
NVAX), a global company advancing protein-based vaccines with its novel Matrix-Mâ„¢ adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units to ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Shares of NVAX stock opened at $8.19 on Wednesday. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of -3.62, a P/E/G ratio of 63.06 and a beta of 2.14. Novavax has a 52 week ...
After hours: February 14 at 7:55:34 PM EST Loading Chart for NVAX ...
Shares of Novavax Inc. NVAX slid 3.09% to $7.83 Wednesday, on what proved to be an all-around mixed trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results